A bone stimulator is an important part of a spinal fusion operation that helps the bone to recover faster. A bone stimulator is a tiny device that sends low-voltage electrical impulses straight to the spine region where bone formation (spine fusion) is about to begin.
New York, June 28, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Spine Bone Stimulators Market Size, Share & Industry Trends Analysis Report By Device Type, By End User, By Regional Outlook and Forecast, 2022 – 2028" - https://www.reportlinker.com/p06289292/?utm_source=GNW It can be internal or external. These devices are usually worn following a spinal fusion. During a spinal fusion, a bone stimulator is employed. Spine bone stimulators, as well as spinal equipment (plates, rods, and screws) and bone grafts, are used during spinal fusion surgery. These stimulators transmit low-level electrical signals to the fusion region, stimulating the body’s natural bone process of healing, which is slowed in at-risk individuals, thus preventing delayed or non-union of spine fractures. According to a report released by the United Spinal Association in August 2020, approximately 296,000 Americans are living with spinal cord injury, and approximately 17,900 new spinal injury cases are reported each year, with men accounting for roughly 78 percent of new spinal cord injury cases. The purpose of spine fusion is to create stability throughout the disc space by joining two freely moving bones and causing them to fuse. This procedure is in direct opposition to how healthy spinal segments should function. When a spinal disc is fully worn out, a spinal bone is fractured, or the vertebrae are slipping on each other, they must be supported and maintained. Surgeons disagree on the ideal way, but much as a cast permits a broken bone to mend, the bones in the spine would not join together unless they have been held still. COVID-19 Impact The Spine Bone Stimulator market is expected to be negatively impacted by the COVID-19 pandemic. The COVID-19 pandemic hampered the detection and treatment of spinal injury in 2020 since it reduced the number of road traffic accidents and outdoor sports activities. Due to a sharp drop in elective surgeries, a ban on organized sports, the momentary shutdown of O&P clinics, hospital availability restricted to non-essential care, limited access to clinics, and slowed in-patient flow and referrals, the pandemic is anticipated to have a short-term negative impact on the bone growth stimulators market. However, crucial European markets, as well as China, are showing indications of recovery. Market Growth Factors Increasing demand of the non-invasive treatment for spine treatment One of the primary factors encouraging the use of such stimulators around the world is the rising incidence of bone illnesses, which is boosting the market growth. Osteoporosis is a leading cause of fractures all over the world. More than 8.9 million fractures are predicted to occur each year, affecting 75 million people in the United States, Europe, and Japan. Furthermore, rising diagnoses of such disorders, as well as the quick development of technologically sophisticated solutions for effective treatment, would aid market growth. Emerging markets and increased R&D activities, along with increasing number of product launches The bone growth stimulators market is likely to offer considerable prospects in emerging economies. As a result of these factors, many physicians, doctors, and health care workers are becoming more aware of the latest treatments available for spine bone stimulators and bone healing, including an increasing number of patients, an increase in healthcare spending, federal programs to support the healthcare market, and a strengthening of export markets. Furthermore, many individuals from mature economies are expected to travel to these emerging markets for medical care due to significant cost savings. Market Restraining Factors High pill loads cause poor medication compliance in patients. Adherence failure is a severe problem that impacts not only the individual but also the healthcare system. Medication non-adherence causes significant disease progression, death, and higher healthcare expenses in patients. Adherence is likely to be affected by several factors. Patient, the provider, and health-care-system issues, as well as interactions between them, could be addressed as adherence barriers. To enhance drug adherence, it would require identifying individual obstacles for each patient and using appropriate ways to overcome them. Physicians, pharmacists, and nurses, for example, play an important role in improving patient medication adherence in their daily practices. Device Type Outlook Based on Device Type, the market is segmented into Non-Invasive and Invasive. The Invasive segment registered a substantial revenue share in the spine bone stimulators market in 2021. External bone growth stimulation gadgets are placed outside the skin following spinal fusion and do not require medical implantation or extraction. The goal is to increase bone formation and enhance fracture healing by inducing osteogenesis. Direct current is given immediately to the fractured site via an implanted electrode in invasive systems. End User Outlook Based on End User, the market is segmented into Hospitals, Specialty Clinics, and Others. The Hospital segment garnered the highest revenue share in the spine bone stimulators market in 2021. As a result of an increase in the amount of orthopedic procedures performed in the hospitals. It employs bone growth stimulation materials for a variety of procedures, including spine surgery, oral and maxillofacial surgery, dental practices, and bone fractures. The key factors driving the growth of the bone growth stimulators market for hospitals are the benefits of bone growth stimulation product lines placed above equivalents, the increasing patient population, rising procedural quantities of orthopedic surgeries, and growing awareness of bone growth stimulation products. Regional Outlook Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa. The North America segment procured the largest revenue share in the spine bone stimulators market in 2021. The spinal bone stimulator market is expected to develop due to an increase in the geriatric population, more patient awareness regarding safe spine fusion surgeries, and an increase in the incidence of spinal illnesses such as osteoporosis and arthritis. The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include DJO Global, Inc. (Enovis), Zimmer Biomet, Orthofix Medical Inc., Elizur Corporation, Ossatec Benelux BV, IGEA S.p.A., ManaMed Inc., Theragen, Inc., Intelligent Implants, and Orchid Medical, Inc. Strategies Deployed in Spine Bone Stimulators Market May-2022: Orthofix Medical received a U.S. Food and Drug Administration for AccelStim bone healing treatment Class III device. The AccelStim device offers an effective and safe nonsurgical therapy for demonstrating fresh fractures and for fractures that have not to cure. Mar-2022: Zimmer Biomet signed an agreement with Biocomposites, an international medical device enterprise. Together the companies aimed to solely administer its Genex bone graft replacement with its new combining system and provide options in the US orthopedic industry. Additionally, genex bone graft substitute tools to surgeons to proceed in business to mitigate enhancement and pain the capacity of life for consumers across the world. Feb-2022: DJO extended its partnership with the Professional Football Athletic Trainers Society, an experienced society composed of authorized athletic coaches working in professional football. Through this partnership, the entities aimed to promote athlete health through schemes such as join the Club, DJO’s precautionary uplifting scheme for high school sportspersons. Sep-2021: DJO, a subsidiary of Colfax Corporation unveiled MedShape DynaNail Hybrid Fusion System. The DynaNail Hybrid adaptive, active healing to deliver cutting-edge, creative automation to patients that would get them back on their feet earlier and keep them effective for longer. Apr-2021: Orthofix Medical signed an agreement to commercialize the innovative suite of IGEA, cartilage, and soft tissue stimulation products in the U.S and Canada. Through this agreement, Orthofix has the right to attempt U.S Food and Drug Administration commercialization and acceptance of IGEA’s policy on orthopedic products, which are not presently accessible in the U.S. Nov-2018: DJO came into a partnership with SirenMD, a technology platform that powers athlete health by connecting the trainers, physicians, and loved ones who treat them. Through this partnership, the companies aimed to address some of the medical carelessness with an integrated telecommunications platform and enhance complete patient healthcare. Scope of the Study Market Segments covered in the Report: By Device Type • Non-Invasive • Invasive By End User • Hospitals • Specialty Clinics • Others By Geography • North America o US o Canada o Mexico o Rest of North America • Europe o Germany o UK o France o Russia o Spain o Italy o Rest of Europe • Asia Pacific o China o Japan o India o South Korea o Singapore o Malaysia o Rest of Asia Pacific • LAMEA o Brazil o Argentina o UAE o Saudi Arabia o South Africa o Nigeria o Rest of LAMEA Companies Profiled • DJO Global, Inc. (Enovis) • Zimmer Biomet • Orthofix Medical Inc. • Elizur Corporation • Ossatec Benelux BV • IGEA S.p.A. • ManaMed Inc. • Theragen, Inc. • Intelligent Implants • Orchid Medical, Inc. Unique Offerings • Exhaustive coverage • Highest number of market tables and figures • Subscription based model available • Guaranteed best price • Assured post sales research support with 10% customization free Read the full report: https://www.reportlinker.com/p06289292/?utm_source=GNW About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________
The U.S. is gearing up for another wave of COVID-19 infections in the fall and winter following a flurry of activity this week.
Is Johnson & Johnson stock a buy after the company unveiled positive results in cancer treatment this month? Is JNJ stock a buy?
Achieving classical herd immunity against SARS-CoV-2 is "unlikely" despite the effectiveness of vaccines, according to health experts. Herd immunity refers to how much of the population needs to be vaccinated or infected with COVID-19 in order to "eradicate or eliminate" the disease. The country's top infectious disease expert Dr. Anthony Fauci spoke about herd immunity during an interview with KCRA 3 and the National Press Foundation.
The infectious-disease expert was feeling "really poorly" and began a second round of Paxlovid.
The Los Angeles-based company is far different from Athenex, developing different kinds of cancer drugs and building its own business model around those plans, but it also has some notable similarities.
Nearly two dozen people have been sickened with listeria, and one has died, according to the Centers for Disease Control and Prevention, which said the source of the outbreak has not been identified.
A patient seeking abortion services at the Women's Reproductive Clinic in Santa Teresa, New Mexico. Robyn Beck /AFP via Getty ImagesI lost my twins in the second trimester of my first pregnancy. One fetus died around 14 weeks, and a month later I went into preterm labor – likely caused by the death of the first and an infection. I delivered the second twin, who appeared perfectly healthy on the ultrasound but was simply not old enough to survive, at 18½ weeks. I grieved for years; these were som
As summer kicks off, it’s also grilling season. But experts warn that you should know the risks before eating that […] The post Hot dogs, sausage, other processed meat even worse for your health when grilled, experts say appeared first on TheGrio.
Born at just 27 weeks, Harrison came into the world with a host of medical challenges — but he hasn't let a single one stand in his way.
The beauty of shopping at Walmart is the sheer variety of products the store offers. You can find everything you need in one convenient spot, whether you're picking up barbecue supplies or a new outfit for Fourth of July celebrations. Walmart even has a pharmacy, where you can easily fill prescriptions or purchase medication to treat any ache or pain. But now, the U.S. Consumer Product Safety Commission (CPSC) has issued a new warning about one common medication sold at Walmart, which you'll wan
A little competition can greatly benefit patients. Shareholders may have a more difficult path to navigate.
(Bloomberg) -- Alphabet Inc.’s Google said it will automatically delete records of user visits to sensitive locations, including abortion clinics, responding to growing concerns that the data could be used to prosecute those seeking reproductive care and other personal services.Most Read from BloombergCrypto Meltdown Claims Rolex and Patek Philippe as VictimsUS Will Face High Gas Prices ‘as Long as It Takes,’ Biden SaysThe Wheels Have Come Off Electric VehiclesNetflix Crashes After ‘Stranger Thi
In the face of significant economic, social and health-related challenges around the world, corporate sustainability has never been more important.
Viruses evolve, and vaccines should too. That was the big-picture takeaway from a pivotal meeting this week of the FDA’s expert advisory panel. The question before them was simple: Ahead of an expected winter surge, should vaccine manufacturers tweak their forthcoming booster shots to target Omicron, or should they stick with the tried-and-true 2020 recipe?
Los Angeles County officials have reported limited local transmission of monkeypox, with some recent cases involving people who attended large events and infected people who haven't traveled out of state.
The FDA is asking COVID-19 vaccine makers to test and produce boosters that target both the original and new BA.4/BA.5 strains of the virus by fall.
There are “super-immunity” particles in llama blood, according to the research.
U.S. regulators are telling COVID-19 vaccine makers to tweak any booster doses intended for fall so they protect against the newest omicron relatives
The move that comes amid growing calls for tech companies to ramp up privacy controls in the wake of last week’s Supreme Court decision to eliminate the constitutional right to an abortion.
Cooking and sharing meals is central to many of our lives—an everyday ritual that keeps us close. But experts say it can also offer a window into your health—if you know what to look out for. In particular, the Alzheimer's Association warns that if you notice one particular thing while cooking, it could alert you to the early stages of cognitive decline, even in the absence of other symptoms. Read on to learn which one change in the kitchen is considered a red flag, and why it's important to be